Spanish biopharmaceutical company Cellerix raises another €27m | AltAssets Private Equity News

Subscribe today

Advanced
Search

Spanish biopharmaceutical company Cellerix raises another €27m

12 Nov 2009

Cellerix, a biopharmaceutical company which develops medicines based on cell therapy, has raised €27m in a venture financing round. This round was led by life science venture capital funds YSIOS Capital Partners, Life Science Partners (LSP) and Ventech.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.